Get a Master's in Biotechnology
For more than 50 years, Florida Tech has challenged engineering, science, and technology students with a rigorous educational curriculum rooted in independent and collaborate research, interdisciplinary classroom studies, and a myriad of real-world learning experiences.
Florida Techs masters in biotechnology program is just one of four graduate level specializations in biology, the others being cell and molecular biology, ecology, and marine biology.
The degree program is flexible with a wide range of course options and a minimum of required courses. Biotechnology curriculum covers general biological and chemical sciences, bioinstrumentation, bioinformatics, microbiology, molecular biology, and cell biology. Research is also a major part of studying at Florida Tech, including opportunities for both on- and off-campus laboratory work, and internships on a variety of projects in molecular medicine, diagnostics, agriculture, and environmental science. Students also have a heavy emphasis on enhancing communication skills through writing reports and giving oral presentations.
Developing medical and environmental technologies and solutions to improve the lives of people and habitats around the world is the focus for both students and faculty in the masters in biotechnology program. With some of the most diverse environments on the planet located near Florida Techs campus, this rapidly advancing field uses living organisms and their components to create products and solve challenges.
As a national research university, Florida Tech provides the tools and skills necessary for students earning a masters in biotechnology to conduct cutting-edge research in all areas of biological sciences, including bacterial genetics, climate change, polar biology, Alzheimers disease, and more. This research-based focus not only prepares graduates for the type of work theyll do in their future career; it also provides an opportunity for their program results to be published in respected scientific journals. Building experience in a myriad of biological sciences disciplines, as well as mastering communication skills, gives students a competitive advantage when being considered by employers.
Students have access to state-of-the-art facilities on campus at the F. W. Olin Physical Sciences Center and the F.W. Olin Life Sciences Building. These facilities offer cutting-edge research laboratories and instrumentation, including gene sequencing, recombinant DNA technology, and tissue culture. Multidisciplinary laboratories offer high-resolution microscopy and imaging, an indoor aquaculture facility, a climate change institute, rooms for NMR spectrometers, photochemistry, glassblowing and computational chemistry, and a four-acre oceanfront marine lab with ready access to field sites.
Other facilities add to the reasons why Florida Tech is a leader in science education:
Biology at Florida Tech is not just something you studyits something you go out into the field and do. A Florida Tech biotechnology masters program engages students in relevant, topical research project in a multidisciplinary learning environment.
The professors in the masters in biotechnology program are experienced, doctoral-level instructors with both research and teaching experience in a wide range of areas related to biotechnology. This includes microbial genetics, bioinformatics, human disease, plant biotechnology, gene modification, sensory systems, nanotechnology, and tissue engineering.
Professors in the graduate biology department aim to create leaders in the field of biology who are ready to begin a career capable of contributing their expertise to solve complex challenges. The biotechnology masters degree program offers extensive student- and faculty-led research opportunities and internships that provide real-world experiences.
Florida Tech is the perfect place for a biotechnology masters degree. The 130-acre campus is located on the Space Coast (so named because of the presence of NASA and the Kennedy Space Center on Cape Canaveral just north of us), minutes away from the Indian River Lagoon, the most diverse estuary in North America.
The area has one of the largest high-tech workforce in the country, with more than 5,000 high-tech corporations and government and military organizations located nearby. This workforce also provides an abundance of internship and employment opportunities. the many local, state, and national agencies, marine environmental consulting firms, public aquaria, mariculture companies, and private marine research organizations offer internships and employment for graduates. Just a few hours away from the Florida Keys and the Everglades, Florida Tech is easily the best candidate for a biotechnology masters degree program.
The multidisciplinary biotechnology program prepares graduates for their career using the latest body of knowledge in the industry and by providing excellent research facilities for conducting state-of-the-art biotechnology research. This real-world experience builds a highly competitive resume that equips graduates for future employment.
Research topics include:
In addition to research activities, graduate students can become members of the scientific societies that support the biotechnology field. Based on laboratory productivity, there may also be a chance to attend scientific meetings and present research findings.
Students in this program also collaborate with graduate students in the closely related areas of nanotechnology and biomedical engineering. Internships can also be arranged anywhere in the country during any semester in the second year of the program.
Biotechnology careers can be found in a variety of positions across many different industries, from research and development to medicine and pharmaceuticals, manufacturing, and environmental technology. Graduates with a masters of science in biotechnology from Florida Tech gain new scientific insights and prepare for careers in biotech managementa dynamic and continually growing career option.
The Occupational Outlook Handbook, published by the US Department of Labors Bureau of Labor Standards (BLS), provides information about specific jobs including median annual pay, working conditions and job outlook, among other things.
According to Bureau, job growth for biological scientists is expected to grow more than 20% through 2018. Employment of biological technicians is projected to grow 10% through 2022. Among biotechnology careers, scientists will be needed to develop genetically engineered crops that increase yields and reduce the amount of pesticides and fertilizer. Job growth will also be in demand for scientists to discover new ways to clean and preserve the environment as well as develop alternative sources of energy, such as biofuels and better sources of renewable biomass.
Employers that have recruited Florida Tech graduates for biotechnology careers include:
Florida Tech students graduating with a masters in biotechnology join cutting-edge companies around the world solving complex biological challenges. Some graduates prefer to continue their academic career and enter a doctoral program in biological sciences at Florida Tech. Along with a chance to further their research, earning a doctorate can increase a students lifelong earning potential and position them as a subject-matter expert.
More:
Biotechnology, M.S. | Florida Tech - FIT
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance - November 16th, 2024
- Department of Biotechnology Launches Webinar Series on Biomanufacturing and Biofoundry Initiative - IBG NEWS - November 16th, 2024
- Multimodal scanning of genetic variants with base and prime editing - Nature.com - November 16th, 2024
- NEW INITIATIVE BY THE ITALIAN EMBASSY IN WASHINGTON ON BIOTECHNOLOGY WITH THE MILKEN INSTITUTE AND LEADING RESEARCHERS AND INDUSTRY EXPERTS -... - November 16th, 2024
- Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at... - November 16th, 2024
- Albany State offers new Master of Science in Integrated Biotechnology program - The Albany Herald - November 16th, 2024
- What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Benzinga - November 16th, 2024
- iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business - Simply Wall St - November 16th, 2024
- PDS Biotechnology Highlights Clinical Progress and Q3 Results - TipRanks - November 16th, 2024
- We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance - November 16th, 2024
- Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St - November 16th, 2024
- APHIS Announces Final Notice on Additional Exemptions for the Movement of Organisms Modified or Produced Through Genetic Engineering - USDA APHIS - November 16th, 2024
- Adaptimmune nears second approval for TCR-T therapy - European Biotechnology News - November 16th, 2024
- Lundbeck reports 18% revenue growth in third quarter - The Pharma Letter - November 16th, 2024
- BioNTech to boost oncology offering with buy of Biotheus - The Pharma Letter - November 16th, 2024
- Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - November 16th, 2024
- WPI Receives Federal Funding to Address Anticipated Demand for Biology and Biotechnology Professionals and Educators - WPI News - November 3rd, 2024
- Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research - College of Computer, Mathematical, and Natural Sciences - November 3rd, 2024
- PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat - November 3rd, 2024
- COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved - Renewable Matter - November 3rd, 2024
- Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire - November 3rd, 2024
- Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter - November 3rd, 2024
- Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter - November 3rd, 2024
- AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter - November 3rd, 2024
- CEO and Chairman of the Executive Board - European Biotechnology News - November 3rd, 2024
- The transformative potential of biotechnology and AI in healthcare - The Armchair Trader - November 3rd, 2024
- U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
- Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
- Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
- Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
- Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
- Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
- Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
- Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
- Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
- Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
- Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
- Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
- Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
- Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
- Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
- Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
- MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
- MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
- Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
- Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
- Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
- Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
- Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
- Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
- Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
- Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
- Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
- What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
- Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
- Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
- Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
- Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
- Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
- Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
- Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
- Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
- Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
- Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
- Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
- Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
- Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
- What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
- Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
- Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
- SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
- Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
- Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
- Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
- Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
- Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022